Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The activation peptides of aspartic proteinases plays role as inhibitors of the active site. Additionally we are shipping Napsin A Aspartic Peptidase Kits (7) and Napsin A Aspartic Peptidase Proteins (5) and many more products for this protein.
Showing 10 out of 101 products:
Human Polyclonal NAPSA Primary Antibody for WB - ABIN493155
Tatnell, Powell, Hill, Smith, Tew, Kay: Napsins: new human aspartic proteinases. Distinction between two closely related genes. in FEBS letters 1999
Show all 4 references for ABIN493155
Human Polyclonal NAPSA Primary Antibody for IHC (p), WB - ABIN657694
Bishop, Sharma, Illei: Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. in Human pathology 2009
Show all 3 references for ABIN657694
Human Monoclonal NAPSA Primary Antibody for IHC, ELISA - ABIN1724854
Aikawa, Kawahara, Hattori, Yamaguchi, Abe, Taira, Azuma, Kage: Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings. in Cancer cytopathology 2011
napsin A is aberrantly expressed in a subset of lymphomas
CK7 (show KRT7 Antibodies), TTF-1 (show NKX2-1 Antibodies) and napsin A are predominantly expressed in primary lung adenocarcinoma patients, with CDX-2 (show CDX2 Antibodies) being inconsistently expressed.
The immunocytochemical expressions of napsin A and p40 in imprint cytology seem to be of great utility for the accurate histological differentiation of lung cancers.
Combining HNF-1beta (show HNF1B Antibodies) and napsin A may distinguish clear cell carcinoma from high-grade serous carcinoma, endometrioid adenocarcinoma and metastatic Krukenberg tumors.
napsin A is another sensitive and specific marker for distinguishing ovarian clear cell tumors (especially adenocarcinomas) from other ovarian tumors
Napsin A is expressed in a broad spectrum of renal neoplasms.
Low expression levels of NAPSA is associated with lung adenocarcinoma.
In diagnosis of ovarian clear cell carcinoma, Napsin A is specific but of intermediate sensitivity.
Napsin A is frequently expressed in ovarian and endometrial clear cell carcinomas.
Data indicate that polyclonal but not monoclonal napsin A antibody has a virtually universal nonspecific labeling in mucinous adenocarcinomas of various sites.
The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.
, asp 4
, aspartyl protease 4
, kidney-derived aspartic protease-like protein
, pronapsin A
, NAP 1
, membrane-associated protein HEM-2
, nck-associated protein 1
, likely ortholog of H. sapiens chromosome 9 open reading frame 156 (C9orf156)
, nef-associated protein 1
, thioesterase NAP1